Features

The authors detail the development of a set of decision support rules for application within a major academic medical center and across its affiliated community satellite sites.
Authors examine different cost control levers the government could use to affect drug pricing and have an impact on treatments selected within clinical pathways. 
Winston Wong, PharmD, explains how the recent policy statement released by the American Society of Clinical Oncology represents a significant step forward for clinical pathways as a whole. 
Edward J Stepanski discusses the underlying tension between payers and providers with respect to the aims of clinical pathways and the recent policy statement released by the American Society of Clinical Oncology. 
The essential role of patient navigation and care coordination services in helping patients to adhere to their treatment plans.
The authors discuss tactics for ensuring appropriate compliance with clinical pathways among health care providers in large-scale health networks.
This article provides a comprehensive review of psoriasis and of the practical obstacles encountered in optimizing care of patients with moderate-to-severe disease.